As of 2025-09-18, the EV/EBITDA ratio of Treace Medical Concepts Inc (TMCI) is -12.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMCI's latest enterprise value is 491.23 mil USD. TMCI's TTM EBITDA according to its financial statements is -38.07 mil USD. Dividing these 2 quantities gives us the above TMCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 23.2x | 20.6x |
| Forward P/E multiples | 22.4x - 25.7x | 22.6x |
| Fair Price | (14.25) - (14.73) | (13.78) |
| Upside | -302.4% - -309.3% | -295.8% |
| Date | EV/EBITDA |
| 2025-09-17 | -12.90 |
| 2025-09-16 | -12.95 |
| 2025-09-15 | -13.20 |
| 2025-09-12 | -13.20 |
| 2025-09-11 | -13.57 |
| 2025-09-10 | -12.84 |
| 2025-09-09 | -13.50 |
| 2025-09-08 | -13.02 |
| 2025-09-05 | -13.12 |
| 2025-09-04 | -13.12 |
| 2025-09-03 | -13.25 |
| 2025-09-02 | -13.12 |
| 2025-08-29 | -13.40 |
| 2025-08-28 | -13.50 |
| 2025-08-27 | -13.53 |
| 2025-08-26 | -13.57 |
| 2025-08-25 | -13.62 |
| 2025-08-22 | -14.00 |
| 2025-08-21 | -13.27 |
| 2025-08-20 | -13.07 |
| 2025-08-19 | -13.15 |
| 2025-08-18 | -12.90 |
| 2025-08-15 | -12.65 |
| 2025-08-14 | -12.75 |
| 2025-08-13 | -12.67 |
| 2025-08-12 | -12.06 |
| 2025-08-11 | -11.82 |
| 2025-08-08 | -11.39 |
| 2025-08-07 | -10.65 |
| 2025-08-06 | -10.30 |
| 2025-08-05 | -10.50 |
| 2025-08-04 | -10.53 |
| 2025-08-01 | -10.08 |
| 2025-07-31 | -10.13 |
| 2025-07-30 | -10.41 |
| 2025-07-29 | -10.51 |
| 2025-07-28 | -10.76 |
| 2025-07-25 | -10.68 |
| 2025-07-24 | -10.83 |
| 2025-07-23 | -11.31 |
| 2025-07-22 | -10.99 |
| 2025-07-21 | -10.71 |
| 2025-07-18 | -10.60 |
| 2025-07-17 | -10.83 |
| 2025-07-16 | -10.93 |
| 2025-07-15 | -10.76 |
| 2025-07-14 | -11.16 |
| 2025-07-11 | -11.18 |
| 2025-07-10 | -11.53 |
| 2025-07-09 | -11.54 |